SCIENTURE HOLDINGS, INC. Cost of Goods Sold (Deprecated 2018-01-31)
SCIENTURE HOLDINGS, INC. (SCNX) reported Cost of Goods Sold (Deprecated 2018-01-31) of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2017-05-15
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-12-31 was -$2.27M.
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $230.67K, a 67.08% decline year-over-year.
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $1.04M, a 172.22% increase year-over-year.
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $16.36K, a 91.38% decline from fiscal 2015.
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $189.84K, a 56.86% decline from fiscal 2014.
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $440.05K, a 53.39% decline from fiscal 2013.
- SCIENTURE HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $944.07K.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | -$2.27M derived: sum of 2 quarters · filed 2017-05-15 | -$2.04M derived: sum of 3 quarters · filed 2017-05-15 | -$999.72K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2016-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$2.04M derived: sum of 2 quarters · filed 2017-03-30 | -$999.72K derived: sum of 3 quarters · filed 2017-03-30 | $16.36K 10-K · filed 2017-03-30 | ||
| 2016-09-30 | $230.67K 10-Q · filed 2016-11-14 | $1.27M derived: sum of 2 quarters · filed 2016-11-14 | $2.29M 10-Q · filed 2016-11-14 | $162.89K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2016-06-30 | $1.04M 10-Q · filed 2016-08-05 | $2.06M 10-Q · filed 2016-08-05 | -$67.78K derived: sum of 3 quarters · filed 2017-05-15 | $632.85K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2016-03-31 | $15.59K 10-Q · filed 2017-05-15 | $1.02M 10-Q · filed 2016-04-20 | -$1.11M derived: sum of 2 quarters · filed 2017-05-15 | -$407.04K derived: sum of 3 quarters · filed 2017-05-15 | -$25.03K derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$422.63K derived: sum of 2 quarters · filed 2017-03-30 | -$40.63K derived: sum of 3 quarters · filed 2017-03-30 | $189.84K 10-K · filed 2017-03-30 | $1.93M 10-K · filed 2016-03-28 | |
| 2015-09-30 | $700.64K 10-Q · filed 2016-11-14 | $1.08M derived: sum of 2 quarters · filed 2016-11-14 | $1.31M 10-Q · filed 2016-11-14 | $1.48M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $382.00K 10-Q · filed 2016-08-05 | $612.47K 10-Q · filed 2016-08-05 | $777.38K derived: sum of 3 quarters · filed 2016-08-05 | $854.54K derived: sum of 4 quarters · filed 2016-08-05 | ||
| 2015-03-31 | $230.46K 10-Q · filed 2016-04-20 | $395.38K derived: sum of 2 quarters · filed 2016-04-20 | $472.53K derived: sum of 3 quarters · filed 2016-04-20 | $523.72K derived: sum of 4 quarters · filed 2016-04-20 | ||
| 2014-12-31 | $164.92K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $242.07K derived: sum of 2 quarters · filed 2016-03-28 | $293.26K derived: sum of 3 quarters · filed 2016-03-28 | $440.05K 10-K · filed 2016-03-28 | ||
| 2014-09-30 | $77.15K 10-Q · filed 2015-11-02 | $128.34K derived: sum of 2 quarters · filed 2015-11-02 | $275.13K 10-Q · filed 2015-11-02 | $527.85K derived: sum of 4 quarters · filed 2015-11-02 | ||
| 2014-06-30 | $51.19K 10-Q · filed 2015-07-30 | $197.98K 10-Q · filed 2015-07-30 | $450.70K derived: sum of 3 quarters · filed 2015-07-30 | $819.37K derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2014-03-31 | $146.79K 10-Q · filed 2015-05-04 | $399.51K derived: sum of 2 quarters · filed 2015-05-04 | $768.18K derived: sum of 3 quarters · filed 2015-05-04 | $890.47K derived: sum of 4 quarters · filed 2015-05-04 | ||
| 2013-12-31 | $252.72K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $621.39K derived: sum of 2 quarters · filed 2015-03-23 | $743.68K derived: sum of 3 quarters · filed 2015-03-23 | $944.07K 10-K · filed 2015-03-23 | ||
| 2013-09-30 | $368.67K 10-Q · filed 2014-10-30 | $490.96K derived: sum of 2 quarters · filed 2014-10-30 | $691.35K 10-Q · filed 2014-10-30 | |||
| 2013-06-30 | $122.29K 10-Q · filed 2014-08-21 | $322.68K 10-Q · filed 2014-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |